Company Filing History:
Years Active: 2006
Title: The Innovations of Marc Francis Herin
Introduction
Marc Francis Herin is a notable inventor based in Perwez, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of synthetic excitatory amino acid prodrugs. His work focuses on addressing neurological and psychiatric disorders through innovative chemical solutions.
Latest Patents
Marc Francis Herin holds 1 patent for his invention titled "Prodrugs of excitatory amino acids." This invention relates to synthetic excitatory amino acid prodrugs and processes for their preparation. The invention further encompasses methods of using and pharmaceutical compositions comprising these compounds for the treatment of various neurological and psychiatric disorders.
Career Highlights
Herin is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. His role involves research and development aimed at creating effective treatments for complex medical conditions. His expertise in the field has positioned him as a valuable asset to the company.
Collaborations
Throughout his career, Marc has collaborated with several esteemed colleagues, including Anne H. Dantzig and James Allen Monn. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical research.
Conclusion
Marc Francis Herin's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions to the development of prodrugs for treating neurological and psychiatric disorders highlight the importance of research in improving healthcare outcomes.